Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account

Table of contents

Details

Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application; Guidance for Industry

FDA-2013-D-1464-0023Other
Document

Details

The document's own metadata, straight from the source system.

Title
Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application; Guidance for Industry
Posted
May 29, 2026
Agency
Food and Drug Administration (FDA)
View on regulations.gov ↗